A report was received on 07 jun 2019 from the physician regarding a (b)(6) male, with a recent history of respiratory difficulty during hemodialysis treatment, who experienced respiratory difficulty, chest pain, tremor, and tingling lips at the time of connection during their second hemodialysis treatment with the nxstage system on (b)(6) 2019.Additional information was received on (b)(6) 2019 from a pharmacist stating treatment was terminated after approximately 50 minutes and the patient was treated with oral polaramine (dose unspecified).The patient recovered without sequelae and has discontinued receiving hemodialysis treatment using nxstage product and therapy.
|